AML1-ETO mediates hematopoietic self-renewal and leukemogenesis through a COX/β-catenin signaling pathway
Yiyun Zhang(Harvard University), Jing-Ruey Joanna Yeh(Harvard University), Justin C. Wheat(Massachusetts General Hospital), Andrew L. Kung(Memorial Sloan Kettering Cancer Center), Xi Chen(Heilongjiang Provincial Hospital), Randall T. Peterson(University of Utah), David A. Sweetser(Massachusetts General Hospital), Amir T. Fathi(Harvard University), Jianfeng Wang(Harvard University), Shan Jin(Harvard University), Hossein Sadrzadeh(Boston University)
Cited by 50
Related Papers
Efficient genome editing in zebrafish using a CRISPR-Cas system
|Nature Biotechnology|2013|3k
Engineered CRISPR-Cas9 nucleases with altered PAM specificities
|Nature|2015|1.7k
In vivo drug discovery in the zebrafish
|Nature Reviews Drug Discovery|2005|1.4k
Targeted gene disruption in somatic zebrafish cells using engineered TALENs
|Nature Biotechnology|2011|628
Use of Zebrafish in Drug Discovery Toxicology
|Chemical Research in Toxicology|2019|550